New metabolizable immunologic adjuvant for human use. X. Long-term serologic and clinical follow-up.
D000276:Adjuvants, Immunologic; D000906:Antibodies / Q000032:analysis; D005500:Follow-Up Studies; D006385:Hemagglutination Inhibition Tests; D006801:Humans; D007252:Influenza Vaccines / Q000009:adverse effects
D000276:Adjuvants, Immunologic; D000906:Antibodies; D007252:Influenza Vaccines